Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
TP53 (Tumor protein P53)
i
Other names:
TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7157
Related tests:
‹
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
MSK-IMPACT (21)
FoundationOne® Heme CDx (10)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
UW-Oncoplex™ (2)
Vysis CLL FISH Probe Kit (2)
Tempus xT Assay (1)
Altera
AML Express™
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® HANDLE HRR NGS Panel
AmoyDx® HRD Complete Panel
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO ctDNA Targeted Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
Blueprint Genetics Comprehensive Hereditary Cancer Panel
BrainTumorNext®
BRCANext®
BRCAplus®
BRCAvantage™ Plus
BreastNext®
BROCA Cancer Risk Panel
CancerNext ®
CancerNext-Expanded®
CNV+ Breast Cancer NGS Panel
ColoNext®
Color’s Hereditary Cancer Tes
ColoSeq™
CONFIRM anti-p53 (DO-7) Primary Antibody
CustomNext-Cancer®
Devyser HBOC NGS
EarlyCDT®-Lung
Empower™ Hereditary cancer test
Find It®
Follow It®
GALEAS™ Hereditary Plus
GenomicsNext™ Liquid Biopsy
Guardant360® Liquid
GYNplus®
InVisionSeq™
Invitae Common Hereditary Cancers Panel
Ion AmpliSeq Colon and Lung Cancer Research Panel v2
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Mammostrat® Breast Cancer Recurrence Assay
MelanomaNext®
Myeloid Molecular Profile
Myriad myRisk® Hereditary Cancer
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NGS Targeted Hotspot Panel
Northstar Select™
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoFocus™ PARPi CDx
OncoFOLLOW
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 60 Plus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Myeloid Assay GX
Oncomine Precision Assay
Oncomine Solid Tumor DNA Kit
Oncomine™ Breast cfDNA Assay
Oncomine™ Colon cfDNA Assay
Oncomine™ Lung cfDNA Assay
Oncomine™ Myeloid MRD Assays
Oncomine Tumor Mutation Load Assay
OncoPanel™ Assay
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
OncoScan™ CNV Plus Assay
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
OvaNext®
P53 (TP53) Deletion FISH Probe Kit
PancNext®
PGDx elio™ plasma resolve assay
PredicineCARE™
ProstateNext®
QVantageᵀᴹ
RenalNext™
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SafeSEQ HNSCC assay
SOPHiA DDM HRD Solution
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
StrataNGS™ Test
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Myeloid MRD Panel
SureSeq™ Pan-Myeloid Panel
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xG+
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
MSK-IMPACT (21)
FoundationOne® Heme CDx (10)
TruSight Oncology 500 Assay (3)
Guardant360 TissueNext™ (2)
UW-Oncoplex™ (2)
Vysis CLL FISH Probe Kit (2)
Tempus xT Assay (1)
Altera
AML Express™
AmoyDx® HANDLE Classic NGS Panel
AmoyDx® HANDLE HRR NGS Panel
AmoyDx® HRD Complete Panel
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
AVENIO ctDNA Expanded Kit
AVENIO ctDNA Surveillance Kit
AVENIO ctDNA Targeted Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO Tumor Tissue Surveillance Kit
AVENIO Tumor Tissue Targeted Kit
Blueprint Genetics Comprehensive Hereditary Cancer Panel
BrainTumorNext®
BRCANext®
BRCAplus®
BRCAvantage™ Plus
BreastNext®
BROCA Cancer Risk Panel
CancerNext ®
CancerNext-Expanded®
CNV+ Breast Cancer NGS Panel
ColoNext®
Color’s Hereditary Cancer Tes
ColoSeq™
CONFIRM anti-p53 (DO-7) Primary Antibody
CustomNext-Cancer®
Devyser HBOC NGS
EarlyCDT®-Lung
Empower™ Hereditary cancer test
Find It®
Follow It®
GALEAS™ Hereditary Plus
GenomicsNext™ Liquid Biopsy
Guardant360® Liquid
GYNplus®
InVisionSeq™
Invitae Common Hereditary Cancers Panel
Ion AmpliSeq Colon and Lung Cancer Research Panel v2
LiquidGx™
LiquidHALLMARK®
LiquidPlex™
Mammostrat® Breast Cancer Recurrence Assay
MelanomaNext®
Myeloid Molecular Profile
Myriad myRisk® Hereditary Cancer
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NGS Targeted Hotspot Panel
Northstar Select™
NovoFocus™ CRC 2.0
NovoFocus™ NSCLC 2.0 Test
NovoFocus™ PARPi CDx
OncoFOLLOW
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 60 Plus Assay
Oncomine Lung Cell-Free Total Nucleic Acid Research Assay
Oncomine Myeloid Assay GX
Oncomine Precision Assay
Oncomine Solid Tumor DNA Kit
Oncomine™ Breast cfDNA Assay
Oncomine™ Colon cfDNA Assay
Oncomine™ Lung cfDNA Assay
Oncomine™ Myeloid MRD Assays
Oncomine Tumor Mutation Load Assay
OncoPanel™ Assay
oncoReveal™ Core LBx
oncoReveal™ Essential LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
OncoScan™ CNV Plus Assay
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
OvaNext®
P53 (TP53) Deletion FISH Probe Kit
PancNext®
PGDx elio™ plasma resolve assay
PredicineCARE™
ProstateNext®
QVantageᵀᴹ
RenalNext™
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SafeSEQ HNSCC assay
SOPHiA DDM HRD Solution
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
StrataNGS™ Test
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Myeloid MRD Panel
SureSeq™ Pan-Myeloid Panel
Target Selector™ NGS Lung Panel
Tempus xF Assay
Tempus xG+
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
›
Associations
(644)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + obinutuzumab
Sensitive: A1 - Approval
venetoclax + obinutuzumab
Sensitive
:
A1
venetoclax + obinutuzumab
Sensitive: A1 - Approval
venetoclax + obinutuzumab
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax
Sensitive: A1 - Approval
venetoclax
Sensitive
:
A1
venetoclax
Sensitive: A1 - Approval
venetoclax
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + idelalisib
Sensitive: A1 - Approval
rituximab + idelalisib
Sensitive
:
A1
rituximab + idelalisib
Sensitive: A1 - Approval
rituximab + idelalisib
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
acalabrutinib
Sensitive: A1 - Approval
acalabrutinib
Sensitive
:
A1
acalabrutinib
Sensitive: A1 - Approval
acalabrutinib
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
idelalisib + ofatumumab
Sensitive: A1 - Approval
idelalisib + ofatumumab
Sensitive
:
A1
idelalisib + ofatumumab
Sensitive: A1 - Approval
idelalisib + ofatumumab
Sensitive
:
A1
TP53 wild-type
Small Lymphocytic Lymphoma
TP53 wild-type
Small Lymphocytic Lymphoma
PCR
Sensitive: A2 - Guideline
PCR
Sensitive
:
A2
PCR
Sensitive: A2 - Guideline
PCR
Sensitive
:
A2
TP53 wild-type
Small Lymphocytic Lymphoma
TP53 wild-type
Small Lymphocytic Lymphoma
FCR
Sensitive: A2 - Guideline
FCR
Sensitive
:
A2
FCR
Sensitive: A2 - Guideline
FCR
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
TP53 wild-type
Small Lymphocytic Lymphoma
TP53 wild-type
Small Lymphocytic Lymphoma
alemtuzumab
Sensitive: A2 - Guideline
alemtuzumab
Sensitive
:
A2
alemtuzumab
Sensitive: A2 - Guideline
alemtuzumab
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.